Who owns Esperion Therapeutics?
- Ticker: ESPR
- CUSIP Number: 29664w105
Tip: Access positions for across all investors
Analyze quarterly positions in Esperion Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Esperion Therapeutics stock
Who bought or sold Esperion Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Daniel D. Thurber | 9.1M | $25M | 3% | Mar 2024 |
|
| Vanguard Group | 5.1M | $15M | 8% | Dec 2023 |
|
| Bellevue Group | 4.2M | $13M | 0% | Dec 2023 |
|
| Meditor | 3.8M | $10M | 0% | Mar 2024 |
|
| Millennium Management | 3.6M | $11M | -39% | Dec 2023 |
|
| Two Sigma Investments | 2.3M | $7.0M | 60% | Dec 2023 |
|
| Two Sigma Advisers | 2.1M | $6.4M | 40% | Dec 2023 |
|
| Jpmorgan Chase & Co | 1.9M | $5.6M | 0% | Dec 2023 |
|
| Tang Capital Management | 1.9M | $5.5M | 0% | Dec 2023 |
|
| D. E. Shaw & Co | 1.2M | $3.6M | 100% | Dec 2023 |
|
| Walleye Trading | 1.2M | $3.5M | 856% | Dec 2023 |
|
| GSA Capital Partners | 1.1M | $3.4M | 1% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 1.1M | $3.3M | -11% | Dec 2023 |
|
| Jacobs Levy Equity Management | 1.1M | $3.2M | -53% | Dec 2023 |
|
| Goldman Sachs Group | 1.1M | $3.2M | -10% | Dec 2023 |
|
| Whitefort Capital Management | 886k | $2.6M | 100% | Dec 2023 |
|
| Citadel Advisors | 664k | $2.0M | -12% | Dec 2023 |
|
| Parallel Advisors | 478k | $1.4M | 0% | Dec 2023 |
|
| Marshall Wace | 458k | $1.4M | -71% | Dec 2023 |
|
| Mariner Investment Group | 400k | $510k | 100% | Dec 2023 |
|
| Citigroup | 381k | $1.1M | 2449% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 352k | $1.1M | -15% | Dec 2023 |
|
| Ikarian Capital | 338k | $1.0M | -81% | Dec 2023 |
|
| Gail Mannix | 283k | $847k | -2% | Dec 2023 |
|
| Jane Street | 276k | $824k | 3% | Dec 2023 |
|
| Caption Management | 257k | $767k | -31% | Dec 2023 |
|
| Monaco Asset Management SAM | 244k | $729k | -79% | Dec 2023 |
|
| UBS Group | 236k | $706k | 658% | Dec 2023 |
|
| Davidson Kempner Capital Management | 223k | $663k | 0% | Dec 2023 |
|
| Highbridge Capital Management | 222k | $663M | -13% | Dec 2023 |
|
| Man Group | 217k | $649k | 339% | Dec 2023 |
|
| Walleye Trading Advisors | 214k | $640k | 100% | Dec 2023 |
|
| NJ State Employees Deferred Compensation Plan | 195k | $583k | 0% | Dec 2023 |
|
| Cubist Systematic Strategies | 185k | $553k | 64% | Dec 2023 |
|
| Bank of America Corporation | 177k | $528k | 69% | Dec 2023 |
|
| 683 Capital Management | 135k | $403k | 100% | Dec 2023 |
|
| Barclays | 121k | $362k | 36% | Dec 2023 |
|
| Gts Securities | 106k | $316k | 647% | Dec 2023 |
|
| Squarepoint Ops | 88k | $262k | 214% | Dec 2023 |
|
| Wolverine Asset Management | 87k | $261k | 0% | Dec 2023 |
|
| Russell Investments | 85k | $253k | -2% | Dec 2023 |
|
| Advisor Group Holdings | 72k | $216k | 1% | Dec 2023 |
|
| Aristeia Capital | 71k | $212k | 0% | Dec 2023 |
|
| Bank of New York Mellon | 65k | $195k | 138% | Dec 2023 |
|
| Bp Wealth Management | 61k | $181k | 100% | Dec 2023 |
|
| Charles Schwab Investment Management | 58k | $173k | 0% | Dec 2023 |
|
| Raymond James & Associates | 57k | $152k | 45% | Mar 2024 |
|
| HighTower Advisors | 51k | $152k | 108% | Dec 2023 |
|
| Hrt Financial | 48k | $143k | -28% | Dec 2023 |
|
| Royal Bank of Canada | 44k | $131k | 337% | Dec 2023 |
|
| Mirabella Financial Services | 42k | $126k | 100% | Dec 2023 |
|
| Graham Capital Management | 42k | $125k | -74% | Dec 2023 |
|
| Daiwa Securities Group | 39k | $115k | -1% | Dec 2023 |
|
| Nomura Holdings | 37k | $112k | -68% | Dec 2023 |
|
| Balyasny Asset Management | 37k | $111k | 100% | Dec 2023 |
|
| T. Rowe Price Associates | 35k | $106k | 0% | Dec 2023 |
|
| Eaton Financial Holdings Company | 34k | $91k | 0% | Mar 2024 |
|
| Principal Financial Group | 34k | $101k | -2% | Dec 2023 |
|
| Kingsview Wealth Management | 32k | $94k | 100% | Dec 2023 |
|
| Stifel Financial | 31k | $94k | -35% | Dec 2023 |
|
| Stoneridge Investment Partners | 29k | $87k | 0% | Dec 2023 |
|
| Private Advisor | 29k | $86k | 1% | Dec 2023 |
|
| Summit Financial | 26k | $69k | 67% | Mar 2024 |
|
| Jump Financial | 26k | $77k | 100% | Dec 2023 |
|
| Bleakley Financial Group | 24k | $73k | -20% | Dec 2023 |
|
| Sawtooth Asset Management | 24k | $73k | -20% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 24k | $71k | -86% | Dec 2023 |
|
| Delta Financial Group | 23k | $70k | 0% | Dec 2023 |
|
| Capital Advisors Wealth Management | 22k | $58k | 100% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 22k | $58k | 100% | Mar 2024 |
|
| Point72 Asia | 20k | $60k | 100% | Dec 2023 |
|
| Foundations Investment Advisors | 20k | $41k | 100% | Dec 2023 |
|
| Credit Suisse | 19k | $58k | 9% | Dec 2023 |
|
| Spire Wealth Management | 18k | $48k | 0% | Mar 2024 |
|
| PSI Advisors | 17k | $51k | 162% | Dec 2023 |
|
| Victory Capital Management | 15k | $45k | 31% | Dec 2023 |
|
| Chicago Partners Investment | 15k | $31k | -49% | Dec 2023 |
|
| Pekin, Singer Strauss Asset Management | 15k | $43k | 0% | Dec 2023 |
|
| Mackenzie Financial | 13k | $40k | -59% | Dec 2023 |
|
| Herbst Group | 10k | $28k | 100% | Mar 2024 |
|
| WT Wealth Management | 10k | $30k | 0% | Dec 2023 |
|
| Captrust Financial Advisors | 10k | $30k | 100% | Dec 2023 |
|
| Private Portfolio Partners | 10k | $30k | 100% | Dec 2023 |
|
| Independent Advisor Alliance | 10k | $30k | 0% | Dec 2023 |
|
| Wetzel Investment Advisors | 5.0k | $9.4k | 400% | Mar 2024 |
|
| Point72 Asset Management | 4.8k | $14k | -100% | Dec 2023 |
|
| O'Dell Group | 4.5k | $14k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 3.8k | $11k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 3.3k | $10k | 3% | Dec 2023 |
|
| Headlands Technologies | 3.2k | $9.6k | 100% | Dec 2023 |
|
| DHJJ Financial Advisors | 2.5k | $6.7k | 67% | Mar 2024 |
|
| Global Retirement Partners | 2.4k | $6.6k | 100% | Mar 2024 |
|
| Us Bancorp | 1.1k | $3.2k | 0% | Dec 2023 |
|
| CWM | 850.00 | $2.0k | 0% | Mar 2024 |
|
| Parkside Financial Bank & Trust | 400.00 | $1.2k | 0% | Dec 2023 |
|
| Benjamin F. Edwards & Company | 325.00 | $999.992500 | 0% | Dec 2023 |
|
| SCBT Financial Corporation | 314.00 | $938.985600 | 0% | Dec 2023 |
|
| Barrett & Company | 300.00 | $804.000000 | 0% | Mar 2024 |
|
| City State Bank | 200.00 | $1.0k | 0% | Mar 2024 |
|
| Cornerstone Planning Group | 123.00 | $368.003700 | 0% | Dec 2023 |
|
| Sunbelt Securities | 100.00 | $268.000000 | 0% | Mar 2024 |
|
| Advisory Services Network | 62.00 | $185.001800 | 100% | Dec 2023 |
|
| TD Waterhouse Canada | 60.00 | $184.998000 | 0% | Dec 2023 |
|
| Elequin Capital | 9.00 | $27.000000 | -10% | Dec 2023 |
|
Who sold out of Esperion Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AQR Capital Management | Sep 2023 | 203k | $199k |
| Virtu Financial | Sep 2023 | 182k | $178k |
| Tudor Investment Corporation | Sep 2023 | 73k | $71k |
| Two Sigma Securities | Sep 2023 | 37k | $36k |
| Mariner Wealth Advisors | Sep 2023 | 26k | $26k |
| Bayesian Capital Management | Sep 2023 | 18k | $17k |
| Wolverine Trading | Sep 2023 | 15k | $15k |
| Warberg Asset Management | Sep 2023 | 13k | $13k |
| Parallax Volatility Advisers | Sep 2023 | 11k | $11k |
| Simplex Trading | Sep 2023 | 11k | $10k |
| China Universal Asset Management | Sep 2023 | 2.7k | $3.0k |
| Cary Street Partner Investment Advisory | Sep 2023 | 550.00 | $539.000000 |
| Trust Co Of Vermont | Sep 2023 | 300.00 | $294.000000 |
| Creative Planning | Sep 2023 | 100.00 | $98.000000 |